CGAS and autoimmune disease: It is a putative inhibitor of innate immunity, consistent with known efficacy in the treatments of autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis.19, 32 A recent in silico analysis suggested that HCQ can disrupt dsDNA binding and the activation of cGAS.17